Table 1.
Clinical characteristics
All (N=15) | High amp (N=7) | Low amp (N=8) | |
---|---|---|---|
Age | |||
Median | 66 | 67 | 66 |
Range | 48–72 | 48–73 | 55–72 |
Sex | |||
Female | 6 (40%) | 4 (57%) | 2 (25%) |
Race | |||
White | 11 (73%) | 7 (100%) | 4 (50%) |
WHO performance status | |||
Restricted activity | 10 (67%) | 4 (57%) | 6 (75%) |
Prior lines of therapy | |||
Median (range) | 3 (1–7) | 2 (1–5) | 3 (2–7) |
Prior treatment with first-line platinum doublet | 100% | 100% | 100% |
Histology | |||
Squamous cell carcinoma | 100% | 100% | 100% |